01.11.2006 | Phase II Studies
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: A Southwest Oncology Group study
Erschienen in: Investigational New Drugs | Ausgabe 6/2006
Einloggen, um Zugang zu erhalten